Metformin pharmacokinetics in nondiabetic pregnant women with polycystic ovary syndrome (Q39754625)

14 September 2017

title

Metformin pharmacokinetics in nondiabetic pregnant women with polycystic ovary syndrome (English)

1 reference

polycystic ovary syndrome

14 September 2017

main subject

1 reference

1 reference

1 reference

1 reference

1 reference

1 reference

corrigendum / erratum

Erratum to: Metformin pharmacokinetics in nondiabetic pregnant women with polycystic ovary syndrome

0 references

author

Ricardo Cavalli

object named as

Ricardo Carvalho Cavalli

7

0 references

Vera Lucia Lanchote

object named as

Vera Lucia Lanchote

2

0 references

Geraldo Duarte

6

object named as

Geraldo Duarte

1 reference

14 September 2017

author name string

Cláudia de Oliveira Baraldi

1

1 reference

14 September 2017

Natalícia de Jesus Antunes

3

1 reference

14 September 2017

Teresa Maria de Jesus Ponte Carvalho

4

1 reference

14 September 2017

Elaine Christine Dantas Moisés

5

1 reference

14 September 2017

publication date

3 May 2011

1 reference

European Journal of Clinical Pharmacology

14 September 2017

published in

1 reference

14 September 2017

volume

67

1 reference

14 September 2017

issue

10

1 reference

14 September 2017

page(s)

1027-1033

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1053-0

14 September 2017

1 reference

Effects of metformin on early pregnancy loss in the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1053-0

Impaired glucose tolerance in pregnant women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1053-0

Impact of insulin resistance on pregnancy complications and outcome in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1053-0

Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1053-0

Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1053-0

Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1053-0

Metformin, pre-eclampsia, and pregnancy outcomes in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1053-0

Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1053-0

Pharmacokinetics during pregnancy: evidence-based maternal dose formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1053-0

Pharmacokinetics of metformin during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1053-0

Population pharmacokinetics of metformin in late pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1053-0

Pharmacokinetics and pharmacodynamics of metformin in healthy subjects and patients with noninsulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1053-0

Measurement of the renal clearance of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1053-0

Effect of pregnancy on the pharmacokinetics of metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1053-0

Obstetric outcome in women with polycystic ovarian syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1053-0

Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1053-0

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1053-0

Pharmacokinetic changes during pregnancy and their clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1053-0

Determination of metformin transfer across the human placenta using a dually perfused ex vivo placental cotyledon model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1053-0

Role of human placental apical membrane transporters in the efflux of glyburide, rosiglitazone, and metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1053-0

Placental passage of metformin in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1053-0

Polycystic ovary syndrome

21 January 2018

1 reference

12 December 2020

Metformin kinetics in healthy subjects and in patients with diabetes mellitus

1 reference

12 December 2020

Prospective analysis of the insulin-resistance syndrome (syndrome X).

1 reference

12 December 2020

Polycystic ovaries and levels of gonadotrophins and androgens in recurrent miscarriage: prospective study in 50 women.

1 reference

12 December 2020

10.1007/S00228-011-1053-0

Identifiers

DOI

1 reference

14 September 2017

1 reference